Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injuryChrister Baeck, Frank Tacke, Alexander Wehr et al.|Gut|2011Cited by 608
TAK1 Suppresses a NEMO-Dependent but NF-κB-Independent Pathway to Liver CancerKira Bettermann, Tom Luedde, Michael Müller et al.|Cancer Cell|2010Cited by 220
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancerCarlo Schneider, Frank Tacke, Andreas Teufel et al.|Gut|2012Cited by 179
RIP3 Inhibits Inflammatory Hepatocarcinogenesis but Promotes Cholestasis by Controlling Caspase-8- and JNK-Dependent Compensatory Cell ProliferationMihael Vucur, Tom Luedde, Florian Reisinger et al.|Cell Reports|2013Cited by 132
The Diagnostic Value of ACSL1, ACSL4, and ACSL5 and the Clinical Potential of an ACSL Inhibitor in Non-Small-Cell Lung CancerYunxia Ma, Nikolaus Gaßler|Cancers|2024Cited by 24